LSC
HQL icon

Logan Stone Capital’s abrdn Life Sciences Investors HQL Stock Holding History

Logan Stone Capital’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-14,778
Closed -$201K – 174
2024
Q1 		$201K Sell
14,778
-136,236
-90% -$1.88M 0.04% 134
2023
Q4 		$2.03M Sell
151,014
-97,602
-39% -$1.2M 0.41% 65
2023
Q3 		$3.1M Buy
248,616
+169,392
+214% +$2.23M 0.85% 39
2023
Q2 		$1.07M Sell
79,224
-73,518
-48% -$1.01M 0.36% 77
2023
Q1 		$2.13M Sell
152,742
-6,081
-4% -$86.9K 0.84% 38
2022
Q4 		$2.26M Buy
+158,823
New +$2.3M 0.84% 32

Other funds holding HQL

Saba Capital Management
Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return
Absolute Investment Advisers
Absolute Investment Advisers Rosemary Beach, Florida $1.03B AUM 1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
1607 Capital Partners
1607 Capital Partners Richmond, Virginia $1.15B AUM 12.28% 1-Year Est. Return
Karpus Investment Management
Karpus Investment Management Pittsford, New York $3.48B AUM 10.49% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Needham Investment Management
Needham Investment Management New York $3.33B AUM 163.16% 1-Year Est. Return
AQR Arbitrage
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
Flagship Harbor Advisors
Flagship Harbor Advisors Boston, Massachusetts $2.61B AUM 23.21% 1-Year Est. Return
RL
RPO LLC Stamford, Connecticut $30.4M AUM 3.41% 1-Year Est. Return

Logan Stone Capital's HQL Position: Q2 2024 in Review

Logan Stone Capital sold out of abrdn Life Sciences Investors (HQL) in Q2 2024, closing a stake of 14,778 shares — an estimated $201K sold.

Logan Stone Capital first reported a position in HQL in Q4 2022 and held it in 6 quarters. The position peaked at $3.1M in Q3 2023. 75 funds tracked by Wall St. Rank hold HQL as of Q2 2024.

  • Logan Stone Capital reported no remaining abrdn Life Sciences Investors position as of Q2 2024 after selling out during the quarter.
  • Logan Stone Capital sold 14,778 abrdn Life Sciences Investors shares in Q2 2024, an estimated $201K.
  • Logan Stone Capital first reported a position in abrdn Life Sciences Investors in Q4 2022 and held it in 6 quarters.
  • Logan Stone Capital's abrdn Life Sciences Investors position peaked at $3.1M in Q3 2023.
  • 75 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q2 2024.

Based on Logan Stone Capital's 13F filing for Q2 2024, filed 14 Aug 2024.